Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments - Additional Information (Details)

v3.24.1.u1
Financial Instruments - Additional Information (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Jan. 17, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Investments in privately held entities $ 11.8 $ 11.8  
Company Y      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Contingent consideration (up to) $ 2.6   $ 2.6